130 related articles for article (PubMed ID: 8511824)
1. A feasibility study on quantitating myocardial perfusion with Albunex, an ultrasonic contrast agent.
Wilson B; Shung KK; Hete B; Levene H; Barnhart JL
Ultrasound Med Biol; 1993; 19(3):181-91. PubMed ID: 8511824
[TBL] [Abstract][Full Text] [Related]
2. Hemodynamic characteristics, myocardial kinetics and microvascular rheology of FS-069, a second-generation echocardiographic contrast agent capable of producing myocardial opacification from a venous injection.
Skyba DM; Camarano G; Goodman NC; Price RJ; Skalak TC; Kaul S
J Am Coll Cardiol; 1996 Nov; 28(5):1292-300. PubMed ID: 8890829
[TBL] [Abstract][Full Text] [Related]
3. Some considerations on the measurements of mean frequency shift and integrated backscatter following administration of Albunex.
Wang SH; Chang PH; Shung KK; Levene HB
Ultrasound Med Biol; 1996; 22(4):441-51. PubMed ID: 8795171
[TBL] [Abstract][Full Text] [Related]
4. [Intrapulmonary arterial injection of Albunex for left heart contrast echocardiography].
Fukui O; Lim YJ; Nakatani D; Kawano S; Kodama K; Masuyama T; Asanuma H; Hori M; Mishima M
J Cardiol; 1998 Feb; 31(2):99-107. PubMed ID: 9513037
[TBL] [Abstract][Full Text] [Related]
5. Digital radiofrequency echocardiography in the detection of myocardial contrast following intravenous administration of Albunex.
Monaghan MJ; Metcalfe JM; Odunlami S; Waaler A; Jewitt DE
Eur Heart J; 1993 Sep; 14(9):1200-9. PubMed ID: 8223734
[TBL] [Abstract][Full Text] [Related]
6. Intracoronary air-filled albumin microspheres for myocardial blood flow measurement.
Rovai D; Ghelardini G; Trivella MG; Björklund G; Nevola E; Taddei L; Distante A; L'Abbate A
J Am Coll Cardiol; 1993 Dec; 22(7):2014-21. PubMed ID: 8245361
[TBL] [Abstract][Full Text] [Related]
7. Intracoronary albunex. Its effects on left ventricular hemodynamics, function, and coronary sinus flow in humans.
Ten Cate FJ; Widimsky P; Cornel JH; Waldstein DJ; Serruys PW; Waaler A
Circulation; 1993 Nov; 88(5 Pt 1):2123-7. PubMed ID: 8222106
[TBL] [Abstract][Full Text] [Related]
8. The influence of intravenous Albunex injections on pulmonary arterial pressure, gas exchange, and left ventricular peak intensity.
Walker R; Wiencek JG; Aronson S; Zaroff J; Glock D; Thisted R; Feinstein SB
J Am Soc Echocardiogr; 1992; 5(5):463-70. PubMed ID: 1389214
[TBL] [Abstract][Full Text] [Related]
9. Albunex: a safe and effective commercially produced agent for myocardial contrast echocardiography.
Keller MW; Glasheen W; Kaul S
J Am Soc Echocardiogr; 1989; 2(1):48-52. PubMed ID: 2627424
[TBL] [Abstract][Full Text] [Related]
10. [Assessment of myocardial perfusion with second harmonic imaging--using intravenous injection of Albunex and Levovist].
Hasegawa M; Saiki Y; Kayano H; Katagiri T
Nihon Rinsho; 1998 Apr; 56(4):903-8. PubMed ID: 9577606
[TBL] [Abstract][Full Text] [Related]
11. On the application of ultrasonic contrast agents for blood flowmetry and assessment of cardiac perfusion.
Bleeker H; Shung K; Barnhart J
J Ultrasound Med; 1990 Aug; 9(8):461-71. PubMed ID: 2204718
[TBL] [Abstract][Full Text] [Related]
12. Intravenous Albunex during transesophageal echocardiography: quantitative assessment by videodensitometry and integrated backscatter analysis from unprocessed radiofrequency signals.
Angermann CE; Krüger TM; Junge R; Drewello R; Stempfle HU; Spes CH; Theisen K
J Am Soc Echocardiogr; 1995; 8(6):839-53. PubMed ID: 8611284
[TBL] [Abstract][Full Text] [Related]
13. Reliability of echocardiographic measurements of myocardial perfusion using commercially produced sonicated serum albumin (Albunex).
Klein AL; Bailey AS; Moura A; Murray RD; Morehead AJ; Brum J; Pearce G; Stewart WJ; Thomas JD
J Am Coll Cardiol; 1993 Dec; 22(7):1983-93. PubMed ID: 8245358
[TBL] [Abstract][Full Text] [Related]
14. Myocardial regional blood flow: quantitative measurement by computer analysis of contrast enhanced echocardiographic images.
Mor-Avi V; David D; Akselrod S; Bitton Y; Choshniak I
Ultrasound Med Biol; 1993; 19(8):619-33. PubMed ID: 8134967
[TBL] [Abstract][Full Text] [Related]
15. Myocardial contrast echocardiography: reliable, safe, and efficacious myocardial perfusion assessment after intravenous injections of a new echocardiographic contrast agent.
Meza M; Greener Y; Hunt R; Perry B; Revall S; Barbee W; Murgo JP; Cheirif J
Am Heart J; 1996 Oct; 132(4):871-81. PubMed ID: 8831379
[TBL] [Abstract][Full Text] [Related]
16. Sonicated albumin in exercise echocardiography: technique and feasibility to enhance endocardial visualization.
Yvorchuk KJ; Sochowski RA; Chan KL
J Am Soc Echocardiogr; 1996; 9(4):462-9. PubMed ID: 8827629
[TBL] [Abstract][Full Text] [Related]
17. On the effect of lung filtering and cardiac pressure on the standard properties of ultrasound contrast agent.
Bouakaz A; de Jong N; Cachard C; Jouini K
Ultrasonics; 1998 Feb; 36(1-5):703-8. PubMed ID: 9651600
[TBL] [Abstract][Full Text] [Related]
18. Italian Society of Cardiovascular Echography (SIEC) Consensus Conference on the state of the art of contrast echocardiography.
Ital Heart J; 2004 Apr; 5(4):309-34. PubMed ID: 15185894
[TBL] [Abstract][Full Text] [Related]
19. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres.
Sanders WE; Cheirif J; Desir R; Zoghbi WA; Hoyt BD; Schulz PE; Quiñones MA
Am Heart J; 1991 Dec; 122(6):1660-5. PubMed ID: 1957761
[TBL] [Abstract][Full Text] [Related]
20. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
